Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Stephen Oxley purchased 27 shares of the stock in a transaction on Wednesday, February 19th. The shares were purchased at an average cost of GBX 1,451 ($18.26) per share, with a total value of £391.77 ($492.98).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 27th, Stephen Oxley acquired 7,407 shares of Johnson Matthey stock. The stock was purchased at an average price of GBX 1,343 ($16.90) per share, for a total transaction of £99,476.01 ($125,174.29).
Johnson Matthey Price Performance
JMAT stock opened at GBX 1,453 ($18.28) on Thursday. The firm has a market cap of £2.43 billion, a P/E ratio of 24.69, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. Johnson Matthey PLC has a 1 year low of GBX 1,295.54 ($16.30) and a 1 year high of GBX 1,917.07 ($24.12). The stock has a 50-day simple moving average of GBX 1,380.58 and a 200-day simple moving average of GBX 1,482.98.
Johnson Matthey Cuts Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, February 4th. Shareholders of record on Thursday, December 5th were issued a GBX 22 ($0.28) dividend. The ex-dividend date was Thursday, December 5th. This represents a yield of 1.47%. Johnson Matthey’s dividend payout ratio is currently 130.84%.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on JMAT. Berenberg Bank dropped their target price on shares of Johnson Matthey from GBX 1,650 ($20.76) to GBX 1,500 ($18.88) and set a “hold” rating for the company in a research report on Thursday, November 28th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 1,800 ($22.65) price objective on shares of Johnson Matthey in a research report on Tuesday, December 17th.
View Our Latest Analysis on JMAT
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- Stock Average Calculator
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Biogen Stock Is Mutating Into a Value Play
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.